419 results on '"Yang, Chao-Yie"'
Search Results
2. Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease
3. Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.
4. Studies of Structure–Activity Relationship of 2‑(Pyrrolidin-1ylmethyl)‑1H‑pyrrole-Based ST2 Inhibitors and Their Inhibition of Mast Cells Activation.
5. Lymphocyte cytosolic protein 1 (L-plastin) I232F mutation impairs granulocytic proliferation and causes neutropenia
6. Editorial: Managing cancer metastasis by tackling anticancer drug resistance
7. The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders
8. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway
9. Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of Lymphoma
10. Enrichment of druggable conformations from apo protein structures using cosolvent-accelerated molecular dynamics.
11. Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity
12. Small-molecule PROTAC degraders of the Bromodomain and Extra Terminal (BET) proteins — A review
13. Discovery of Pyrrolo[2,3-c]pyridines as Potent and Reversible LSD1 Inhibitors
14. Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors
15. Identification of cell division cycle protein 20 in various forms of acute and chronic kidney injury in mice
16. Comparative Analyses of the Conformational Dynamics Between the Soluble and Membrane-Bound Cytokine Receptors
17. The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders
18. Correction to “Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) Domains”
19. Supplementary Figures from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
20. Supplementary Tables from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
21. Supplementary Data from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
22. Supporting Information: Tables from Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer
23. Supporting Information: Figures from Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer
24. Supporting Information: Methods from Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer
25. Data from Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer
26. Data from LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNFα Expression and Receptor Tyrosine Kinase Signaling
27. Supplementary Table 1 from LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNFα Expression and Receptor Tyrosine Kinase Signaling
28. Supplementary Methods, Figures 1-12 from LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNFα Expression and Receptor Tyrosine Kinase Signaling
29. Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) Domains
30. Novel, Brain-Permeable, Cross-Species Benzothiazole Inhibitors of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Dampen Neuroinflammation In Vitro and In Vivo
31. Novel Chemical Series of Anti-ST2 Small Molecules Suppress Allogeneic T Cells Proliferation While Increasing Treg Cells and Improve Gvhd and Survival In Vivo
32. Splicing Analysis Unveils Convergent Transcriptomic Pathways in U2AF1 S34 and Q157 Mutant Myeloid Neoplasia
33. Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer.
34. Identification of cell division cycle protein 20 in various forms of acute and chronic kidney injury in mice.
35. Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
36. RNF111-Dependent Neddylation Activates DNA Damage-Induced Ubiquitination
37. Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer.
38. Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding
39. Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors
40. Structure-Activity Relationship of 1-(Furan-2ymethyl)Pyrrolidinebbased Stimulation-2 (ST2) Inhibitors for Treating Graft Versus Host Disease
41. Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
42. Lymphocyte Cytosolic Protein 1 I232F Mutation Impairs Granulocytic Proliferation with a G2/M Block in Severe Neutropenia
43. Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
44. Targeting Inhibitors of Apoptosis Proteins (IAPs) For New Breast Cancer Therapeutics
45. Small-Molecule U2 Auxiliary Factor Homology Motif (UHM) Domain Inhibitors Cause Splicing Pattern Changes in U2AF1 Mutant Leukemia Cells and Induce Sub-G1 Cell Cycle Arrest
46. Differential Isoforms Signature of Splicing Factor Mutant Myeloid Neoplasia
47. N-terminal modified cyclopeptidic mimetics of ApolloTBM as inhibitors of TRF2
48. The Immunogenetic Basis of Idiopathic Bone Marrow Failure Syndromes: A Paradox of Similarity and Self-Presentation
49. SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
50. A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.